Study claims Ozempic may also help reduce dementia risk
Weight loss drug Ozempic may also reduce the risk of dementia, suggests a new study.
American researchers found that semaglutide - the active ingredient in Ozempic and another weight loss medication, Wegovy - may lower the risk of dementia in people with type 2 diabetes.
Scientists say that dementia occurs when brain cells are damaged and their connections stop working properly.
That damage, which worsens over time, can be caused by various modifiable factors, including obesity, diabetes, cardiovascular diseases, traumatic brain injury and stroke.
Previous research has indicated that 45% of dementia cases could be prevented by addressing modifiable risk factors.
The new study suggests type 2 diabetes patients taking semaglutide had a "significantly lower" risk of developing dementia compared to other antidiabetic medications.
The results were more "profound" in women and older adults, according to the findings published in the Journal of Alzheimer's Disease.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) molecule that decreases hunger and helps regulate blood sugar in diabetes, has previously shown several health benefits, including reductions in cardiovascular diseases.
Researchers at Case Western Reserve School of Medicine in Cleveland, Ohio, analyzed three years of electronic records of nearly 1.7 million American type 2 diabetes patients.
The team used a statistical approach that mimics a randomised clinical trial.
They found patients prescribed semaglutide had a "significantly" lower risk for Alzheimer's disease-related dementia, compared to those who had taken any of seven other anti-diabetic medications, including other types of GLP-1R-targeting medications.
Study leader Professor Rong Xu said: "There is no cure or effective treatment for dementia, so this new study provides real-world evidence for its potential impact on preventing or slowing dementia development among at-risk populations."
Although the findings potentially support the idea that semaglutide could prevent dementia, Prof Xu says the study's limitations restrict the team from making firm causal conclusions.
She added: "Our results indicate that research into semaglutide's use for dementia prevention will need to be further investigated through randomised clinical trials."
The post Study claims Ozempic may also help reduce dementia risk appeared first on Talker.
Copyright Talker News. All Rights Reserved.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Novo Nordisk Ignored Internal Warnings On Wegovy Launch Preparedness: Report
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Novo Nordisk A/S' (NYSE:NVO) executives allegedly ignored internal warnings that the company was unprepared to launch its obesity drug Wegovy. As rival Eli Lilly and Co.'s (NYSE:LLY) Zepbound gains momentum, the Danish pharmaceutical giant is grappling with the fallout of those early decisions. Wegovy, approved in the U.S. in mid-2021, marked a major advancement in obesity treatment and helped Novo generate $46 billion in net profit since then. Trending: Tired of Grid Failures and Charging Deserts? This Startup Has a Solar Fix and $25M+ in Sales — But the company has struggled to keep pace with Lilly's Zepbound, which has surpassed Wegovy in weekly new prescriptions this year. Amid concerns over its competitiveness in the weight-loss market, Novo is undergoing a leadership shake-up, including the recent dismissal of CEO Lars Fruergaard Jorgensen and earlier departures like U.S. chief Doug Langa. Sources told Reuters that during tense internal meetings, sales and marketing staff warned Langa about launching Wegovy too quickly after FDA approval. They urged a delay until supply and insurance coverage were more secure. With a list price of up to $1,300 per month, many patients found the drug unaffordable without insurance, and Novo missed an opportunity to build a more stable launch pad while Lilly's market entry was still years company leadership in Copenhagen held to conservative sales expectations through 2025, Reuters report highlighted, underestimating the scale of demand driven by the global obesity epidemic. Former employees said Novo had internal indicators pointing to stronger uptake but failed to adjust its strategy accordingly. The consequences were swift. Wegovy's launch was plagued by supply shortages, leaving patients without doses and discouraging new users. The high cost also pushed some patients toward the gray market of compounded drugs. Novo further faced criticism for pricing Wegovy significantly higher than its diabetes drug Ozempic, while Lilly entered the market with Zepbound at $1,080 and provided steep discounts through its LillyDirect pharmacy. One former insider claimed that Novo hesitated to offer competitive rebates to pharmacy benefit managers (PBMs), limiting the drug's accessibility. This reluctance hurt relationships with insurers and failed to secure broader coverage, placing Novo at a disadvantage compared to Lilly's aggressive pricing and reimbursement strategies. Recently, Novo Nordisk launched its weight-loss drug Wegovy (semaglutide) in India to compete with Eli Lilly. Read Next: $100k+ in investable assets? Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes – no cost, no obligation. If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it? Photo by Tobias Arhelger via Shutterstock This article Novo Nordisk Ignored Internal Warnings On Wegovy Launch Preparedness: Report originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
Ozempic-Like Drugs Could Treat Chronic Migraines, Trial Finds
Medications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but that only scratches the surface of what these injections are potentially capable of. Originally designed to treat type 2 diabetes, GLP-1 agonists have also shown unforeseen benefits to heart, brain, liver, and kidney health – and now, it seems, the head, alleviating migraines in a new study. In a pilot trial of 31 patients with high BMI and frequent or chronic migraines, participants who received a daily injection of the GLP-1 agonist liraglutide experienced significantly fewer painful headaches. After 12 weeks, the number of days with a migraine each month decreased from a mean of 19.8 days to just 10.7 days – a reduction of nearly half. Related: Weight loss, age, sex, and the use of other medications at the same time did not significantly alter the results. "Our findings show that liraglutide may be effective in the treatment of unresponsive high-frequency or chronic migraine in patients with obesity, and that this effect is independent from weight loss," conclude the authors, who hail from the University of Naples in Italy. "This suggests… that the mechanisms driving liraglutide's effectiveness in migraine prevention may operate independently of the significant metabolic effects… " Further studies with larger cohorts and a control group are needed to verify that hypothesis. But GLP-1 agonists, like liraglutide and possibly even its longer-lasting relative semaglutide, may prove to be a promising route for future migraine treatments. Migraines impact an estimated 14 to 15 percent of the global population, and yet the few medications we have on hand do not work for everybody. "A substantial number of patients still face an unmet need, especially when preventive drugs prove ineffective," writes a team of scientists led by neurologist Simone Braca. Participants in the current pilot trial had migraines unresponsive to other treatments, meaning liraglutide worked where other drugs had not. GLP-1 agonists slow appetite and help regulate blood sugar by mimicking a natural hormone in the body, called glucagon-like peptide-1, which is released after eating. That's why these drugs are so effective when it comes to managing type 2 diabetes and weight gain. But GLP-1 receptors exist throughout the body, in many different tissues and organs. The fact that liraglutide and similar medications have widespread effects outside of the pancreas makes logical sense. Still, scientists are trying to figure out what those effects are, and whether they help or harm. In recent years, studies have shown liraglutide and other GLP-1 agonists can greatly reduce intracranial pressure in the brain – a speculative trigger for migraines. In animal models, these drugs have also suppressed migraines with great effectiveness. The current pilot trial is only small and it did not investigate the mechanisms behind liraglutide's migraine relief, nor did it directly measure intracranial pressure among participants. Nevertheless, Braca and her colleagues suspect that reduced pressure in the skull is playing a role in migraine reduction. In recent animal studies, GLP-1 agonists reduced fluid in the central nervous system, thereby lowering intracranial pressure. "These findings provide a foundation for larger-scale trials aimed at further investigating the role of GLP-1R agonists in migraine management," Braca and her team conclude. The study was published in Headache. Gut Bacteria Found to Soak Up Toxic Forever Chemicals Gene Therapy Can Restore Hearing in Adults, First-of-Its-Kind Trial Shows Cheese May Actually Fuel Nightmares, Surprising Study Confirms
Yahoo
6 hours ago
- Yahoo
8 Foods You Should Be Eating Every Week If You Have High Blood Pressure, According to Dietitians
Reviewed by Dietitian Karen Ansel, M.S., RDNNearly half of American adults have high blood pressure, also known as hypertension. We're often told to avoid sodium, yet many foods are naturally rich in blood pressure–lowering nutrients. Potassium, magnesium, calcium, fiber and omega-3 fats may help reduce blood blood pressure, or hypertension, affects roughly half of American adults. While many people need medication to control this condition, regularly eating certain foods can also help lower your blood pressure—no prescription required. So, what are these power foods? To find out, we asked dietitians the best blood pressure–lowering foods to add to your weekly rotation. Get out your pen and paper (or smartphone!) because you're going to want to make sure these eight foods are at the top of your shopping list. Bananas are nutrient gold mines when it comes to better blood pressure, says Natalie Rizzo, M.S., RDN. For starters, she says, bananas are a good source of potassium. This mineral helps lower blood pressure by decreasing the stress on blood vessel walls caused by eating too much sodium. Even though most of us consume too much sodium, few of us get enough potassium. That's where bananas come in. One medium banana provides roughly 420 milligrams of potassium, or 9% of the Daily Value. Bananas also provide fiber, which helps lower blood pressure by producing compounds called short-chain fatty acids that help relax blood vessels and improve blood flow. Yet, like potassium, most of us don't consume nearly enough fiber. One medium banana delivers an easy 3 grams of fiber, which is roughly 11% the 28-gram DV. If beets aren't already on your list of heart-healthy foods, they should be! These deep purple veggies contain dietary nitrates, compounds your body converts to a blood pressure–lowering nitric oxide. That's not all. They give you 442 mg of potassium per cup (9% of the DV). So, toss some in your next salad. Or, if you want even more blood pressure–lowering power, pour a glass of beet juice. Research has shown it can significantly reduce systolic blood pressure, the blood pressure reading most closely related to heart disease risk. Soy foods like edamame are powerful players when it comes to lowering blood pressure. The proof is so strong that one systematic review and meta-analysis of 17 studies found that eating soy foods can significantly reduce both systolic and diastolic blood pressure. If you're wondering what makes edamame so effective, the answer may lie in their nutrient density. One cup of shelled edamame packs an impressive 8 grams of fiber. That's more than a quarter of your daily requirement. It also contains 14% of the DV for potassium, plus other blood pressure–lowering minerals like magnesium and calcium. 'Regular consumption of pistachios has been shown in several studies to help reduce blood pressure,' says Kelly Jones, M.S., RD, CSSD. One reason is their fiber. 'Per 1-ounce serving, pistachios provide 3 grams of fiber, a nutrient emphasized by the DASH diet,' says Jones., If you haven't heard of the DASH diet before, it's a blood pressure–lowering eating pattern backed by decades of research. In addition to fiber, pistachios also contain a potent blood pressure–lowering cocktail of potassium, magnesium, calcium, antioxidants and plant protein. 'Although potatoes get a bad reputation, they are full of nutrition and are a good source of potassium,' says Rizzo. 'Since potassium works with sodium to regulate blood pressure, increasing potassium intake is another strategy to help improve blood pressure,' adds Jones. One medium potato delivers 952 mg of potassium. That's 20% of your daily requirement and more than double the amount you'd get from a medium banana. Pulses like beans, lentils and dried peas are an integral part of the DASH diet. Like many other foods on this list, they're rich in potassium and plant protein. But don't just munch on them for their blood pressure benefits. Research has also shown that pulses may lower cholesterol and inflammation and protect against heart attack and cardiovascular disease. You may have heard that omega-3-rich fatty fish like salmon are fantastic foods for heart health. One reason is their favorable impact on blood pressure. Research has found that the long-chain omega-3 fats docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) help relax the muscles of the blood vessel walls. This process, known as vasodilation, allows blood to move easily throughout the body, ultimately reducing blood pressure. Yogurt isn't just great for your gut health. One study found that people with hypertension who frequently consumed yogurt had lower systolic blood pressure. This study didn't find that yogurt had the same impact on people with normal blood pressure. However, another study found that people with healthy blood pressure who regularly ate yogurt were less likely to develop hypertension. While more research is needed, yogurt boasts a long list of health benefits, including lower cholesterol levels and better heart and digestive health. So, tossing a few containers into your shopping cart can do all kinds of good things for your body. Calcium. Calcium is a key mineral for healthy blood pressure. It is believed to work by helping blood vessels relax and favorably impacting hormones that regulate blood pressure. In addition to yogurt, you can get calcium from dairy milk, fortified plant milks, cheese, sardines and salmon with bones. Fiber. Research shows that the more soluble fiber people eat, the lower their blood pressure tends to be. You'll find soluble fiber in oats, barley, beans and legumes, fruits, vegetables, nuts and seeds. Magnesium. This tiny but mighty mineral plays a role in more than 300 enzymatic reactions in your body. So, it should come as no surprise that it's instrumental for healthy blood pressure. Magnesium-rich foods include pumpkin and chia seeds, almonds, cashews, peanuts, spinach, edamame and soy milk. Long-Chain Omega-3 Fatty Acids. DHA and EPA are found in fatty fish like salmon, mackerel, herring, sardines and anchovies. They promote heart health by regulating blood pressure and reducing inflammation. If you're not a fish eater, speak to your health care provider to find out if a supplement is right for you. Potassium. We often hear that people with high blood pressure should limit sodium, says Jones. And they should! However, the opposite is true when it comes to potassium, which works to offset some of sodium's blood pressure–raising action. You'll find it in every food on this list! Whether you have high blood pressure or simply want to prevent it, there's a long list of foods that can keep your blood pressure in a healthy range. These include bananas, beets, edamame, pistachios, potatoes, pulses, salmon and yogurt. These tasty, nutrient-packed foods are rich in blood pressure–regulating nutrients like potassium, magnesium, calcium, fiber and omega-3 fatty acids. Plus, they're convenient and accessible. No wonder dietitians are such big fans! So, when you make your next grocery run, toss any (or all!) of them in your cart. Because better blood pressure is as much about what you do eat as what you don't. Read the original article on EATINGWELL
